Momeni Arash, Januszyk Michael, Wan Derrick C
Division of Plastic and Reconstructive Surgery, Stanford University Medical Center, Palo Alto, CA.
J Craniofac Surg. 2017 Jul;28(5):1236-1241. doi: 10.1097/SCS.0000000000003683.
Craniofacial distraction osteogenesis (DO) is a common treatment modality today. Despite its numerous advantages, however, concerns have been expressed regarding the use of DO in the irradiated setting.
A systematic review was performed to identify all published reports of patients who underwent DO of the irradiated craniofacial skeleton. The following parameters were of particular interest: postoperative complications, specifically, insufficient bone formation, fracture, and hardware exposure (intraoral and cutaneous), as well as the need for additional bone grafting.
The initial search retrieved a total of 183 articles of which 20 articles (38 patients) met predetermined inclusion criteria. The most common site of distraction was the mandible (76.3%). The median radiation dose was 50.7 Gy (range, 30-70 Gy). Bone defects ranged from 30 to 80 mm (median, 42.5 mm). Complications were encountered in 19 patients (50%), with insufficient bone formation being most common (9 patients; 23%). The overall incidence of complications was not significantly associated with radiation dosage (P = 0.79). The remaining procedural and demographic variables also failed to meet statistical significance when compared against the overall complication rate (P = 0.27-0.97).
The complication rate associated with craniofacial DO of the irradiated skeleton does not appear to be substantially higher than what is reported for DO in the nonirradiated setting. As such, patients should be offered this treatment modality, particularly in light of the fact, that it offers the option to decrease patient morbidity as well as treatment complexity.
颅面骨牵引成骨术(DO)是当今一种常见的治疗方式。然而,尽管它有诸多优点,但人们对在放疗后的情况下使用DO仍存在担忧。
进行了一项系统综述,以确定所有已发表的关于接受放疗的颅面骨骼DO治疗患者的报告。以下参数特别令人关注:术后并发症,具体而言,骨形成不足、骨折和硬件暴露(口腔内和皮肤),以及额外骨移植的需求。
初步检索共获得183篇文章,其中20篇文章(38例患者)符合预定的纳入标准。最常见的牵引部位是下颌骨(76.3%)。中位辐射剂量为50.7 Gy(范围,30 - 70 Gy)。骨缺损范围为30至80毫米(中位值,42.5毫米)。19例患者(50%)出现并发症,其中骨形成不足最为常见(9例患者;23%)。并发症的总体发生率与辐射剂量无显著相关性(P = 0.79)。与总体并发症发生率相比,其余的手术和人口统计学变量也未达到统计学显著性(P = 0.27 - 0.97)。
放疗后骨骼的颅面DO相关并发症发生率似乎并不显著高于未放疗情况下DO的报道。因此,应向患者提供这种治疗方式,特别是鉴于它提供了降低患者发病率以及治疗复杂性的选择。